PHOTOPHERESIS PRODUCTS MARKET ANALYSIS

Photopheresis Products MarketSize and Trends

Photopheresis Products Market Drivers

Rise in prevalence of autoimmune diseases and increase in number of organ transplant cases is expected to lead to growth of the photopheresis products market. Increasing reimbursement policies by governments also expect to boost the photopheresis product market. For instance, in August 2016, Mallinckrodt Pharmaceuticals, a leading specialty pharmaceutical company, announced that Switzerland’s Federal Department of Home Affairs (FDHA) approved the reimbursement of ECP treatment for patients in Switzerland.

Furthermore, business strategies such as collaborations by key players in the photopheresis field, helps to improve the understanding of photopheresis’ effect on immune modulations across several severe and critical conditions. For instance, on February 2019, Mallinckrodt plc. announced the research collaboration agreement with Transimmune AG, a company developing novel immunotherapies, for the development of the activation of antigen presenting cells. Both companies intend to explore the next generation Mallinckodt photopheresis system.